IBS-like symptoms in patients with ulcerative colitis

Clinical and Experimental Gastroenterology
David J Gracie, A C Ford

Abstract

Ulcerative colitis (UC) and irritable bowel syndrome (IBS) are chronic gastrointestinal disorders that, until recently, have been considered dichotomous conditions falling on either side of a functional-organic divide. However, persistent gastrointestinal symptoms, akin to those of IBS, are observed in up to one in three patients with quiescent UC. Whether these lower gastrointestinal symptoms are secondary to coexistent IBS or occult UC disease activity is uncertain, but when objective evidence of disease activity is lacking, escalation of conventional pharmacotherapy in such patients is often ineffective. The etiologies of both UC and IBS remain unclear, but dysregulation of the enteric nervous system, an altered microbiome, low-grade mucosal inflammation, and activation of the brain-gut axis is common to both; this suggests that some overlap between the two conditions is plausible. How best to investigate and manage IBS-type symptoms in UC patients remains unclear. Studies that have assessed patients with UC who meet criteria for IBS for subclinical inflammation have been conflicting in their results. Although evidence-based treatments for IBS exist, their efficacy in UC patients reporting these types of symptoms remains unc...Continue Reading

Citations

Oct 6, 2016·Journal of Neurogastroenterology and Motility·Jung Hwan Oh
Mar 16, 2017·ACS Chemical Neuroscience·Md Sharif ShajibWaliul I Khan
May 5, 2017·Alimentary Pharmacology & Therapeutics·C NortonA Hart
Mar 2, 2016·Therapeutic Advances in Gastroenterology·Eamonn M M Quigley
Feb 1, 2020·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Stavroula A TheofanousGuy E Boeckxstaens
Jun 2, 2017·World Journal of Gastroenterology : WJG·Natalia PedersenPia Munkholm
Jul 5, 2016·Alimentary Pharmacology & Therapeutics·C DaiM-J Sun
Nov 22, 2019·Frontiers in Immunology·Ruibing YangXi Sun
Feb 10, 2021·Journal of Basic and Clinical Physiology and Pharmacology·Vijay L KumarHilal Ahmad
Aug 11, 2020·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Dan WangLuqin Si
Aug 15, 2021·Revista De Gastroenterología De México·O Gómez-Escudero, J M Remes-Troche
Jun 3, 2021·Revista de gastroenterología de México·O Gómez-Escudero, J M Remes-Troche

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
pharmacotherapy

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

© 2022 Meta ULC. All rights reserved